S
Sho Iketani
Researcher at Aaron Diamond AIDS Research Center
Publications - 32
Citations - 5070
Sho Iketani is an academic researcher from Aaron Diamond AIDS Research Center. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 7, co-authored 16 publications receiving 1220 citations. Previous affiliations of Sho Iketani include Columbia University.
Papers
More filters
Journal ArticleDOI
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Pengfei Wang,Manoj S. Nair,Lihong Liu,Sho Iketani,Sho Iketani,Yang Luo,Yicheng Guo,Maple Wang,Jian Yu,Baoshan Zhang,Peter D. Kwong,Peter D. Kwong,Barney S. Graham,John R. Mascola,Jennifer Y Chang,Jennifer Y Chang,Michael T. Yin,Michael T. Yin,Magdalena E. Sobieszczyk,Magdalena E. Sobieszczyk,Christos A. Kyratsous,Lawrence Shapiro,Lawrence Shapiro,Zizhang Sheng,Yaoxing Huang,David D. Ho,David D. Ho +26 more
TL;DR: In this paper, the authors show that B.1.7 is refractory to neutralization by most monoclonal antibodies against the N-terminal domain of the spike protein and is relatively resistant to a few monoclanal antibody against the receptor-binding domain.
Posted ContentDOI
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
Pengfei Wang,Manoj S. Nair,Lihong Liu,Sho Iketani,Sho Iketani,Yang Luo,Yicheng Guo,Maple Wang,Jian Yu,Baoshan Zhang,Peter D. Kwong,Peter D. Kwong,Barney S. Graham,John R. Mascola,Jennifer Y Chang,Jennifer Y Chang,Michael T. Yin,Michael T. Yin,Magdalena E. Sobieszczyk,Magdalena E. Sobieszczyk,Christos A. Kyratsous,Lawrence Shapiro,Lawrence Shapiro,Zizhang Sheng,Yaoxing Huang,David D. Ho,David D. Ho +26 more
TL;DR: In this paper, the authors report that B.1.7 is refractory to neutralization by most mAbs to the N-terminal domain (NTD) of spike and relatively resistant to a number of mabs to the receptor-binding domain (RBD).
Journal ArticleDOI
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Sho Iketani,Lihong Liu,Yicheng Guo,Liyuan Liu,Jasper Fuk-Woo Chan,Yiming Huang,Maple Wang,Yang Luo,Jian Yu,Hin Chu,Kenn Ka-Heng Chik,Terrence Tsz-Tai Yuen,Michael T. Yin,Magdalena E. Sobieszczyk,Yaoxing Huang,Kwok-Yung Yuen,Harris H. Wang,Zizhang Sheng,David D. Ho +18 more
TL;DR: The identification of the Omicron (B.1.1) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Botswana in November 20211 immediately caused concern owing to the number of alterations in the spike glycoprotein that could lead to antibody evasion as discussed by the authors .
Posted ContentDOI
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7.
Pengfei Wang,Manoj S. Nair,Lihong Liu,Sho Iketani,Sho Iketani,Yang Luo,Yicheng Guo,Maple Wang,Jian Yu,Baoshan Zhang,Peter D. Kwong,Peter D. Kwong,Barney S. Graham,John R. Mascola,Jennifer Y Chang,Jennifer Y Chang,Michael T. Yin,Michael T. Yin,Magdalena E. Sobieszczyk,Magdalena E. Sobieszczyk,Christos A. Kyratsous,Lawrence Shapiro,Lawrence Shapiro,Zizhang Sheng,Yaoxing Huang,David D. Ho,David D. Ho +26 more
TL;DR: In this paper, the authors report that B.1.7 is refractory to neutralization by most mAbs to the N-terminal domain (NTD) of spike and relatively resistant to a few mabs to the receptor-binding domain (RBD).
Journal ArticleDOI
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Yicheng Guo,Sho Iketani,Manoj S. Nair,Zhiteng Li,Hiroshi Mohri,Maple Wang,Jian Yu,Anthony D. Bowen,Jennifer S. Chang,Jayesh Shah,Nadia Nguyen,Zhiwei Chen,Kathrine Meyers,Michael T. Yin,Magdalena E. Sobieszczyk,Zizhang Sheng,Yaoxing Huang,Lihong Liu,David D. Ho +18 more
TL;DR: A systematic antigenic analysis of the SARS-CoV-2 Omicron subvariants BA.12.2.1 and BA.4.4/5 was performed in this article .